Sustained release of risperidone from biodegradable microspheres prepared by in-situ suspension-evaporation process.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International journal of pharmaceutics

• Publication date

  2016-04-30

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.ijpharm.2016.02.023PMID 26899975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a novel 3-month drug releasing risperidone microspheres

  2015cited by this paper
• In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.

  2015cited by this paper
• Development of Risperidone PLGA Microspheres

  2014cited by this paper
• FORMULATION AND EVALUATION OF OCTREOTIDE ACETATE LOADED PLGA MICROSPHERES

  2013cited by this paper
• Long-Acting Injectable Antipsychotics: Evidence of Effectiveness and Use

  2013cited by this paper
• In Vitro–In Vivo Correlations of Scalable PLGA-Risperidone Implants for the Treatment of Schizophrenia

  2010cited by this paper
• Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.

  2009cited by this paper
• How porosity and size affect the drug release mechanisms from PLGA-based microparticles.

  2006cited by this paper
• Key parameters affecting the initial release (burst) and encapsulation efficiency of peptide-containing poly(lactide-co-glycolide) microparticles.

  2006cited by this paper
• Intestinal uptake and biodistribution of novel polymeric micelles after oral administration.

  2006cited by this paper
• Synthesis control and characterization of hydroxyapatite prepared by wet precipitation process

  2004cited by this paper
• Clinical review of a long-acting, injectable formulation of risperidone.

  2004cited by this paper
• Preparation and Comprehensive Characterization of a Calcium Hydroxyapatite Reference Material

  2004cited by this paper
• Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia.

  2004cited by this paper
• The effects of molecular weight and porosity on the degradation and drug release from polyglycolide.

  2004cited by this paper
• Control of encapsulation efficiency and initial burst in polymeric microparticle systems

  2004cited by this paper
• Efficacy of newer generation antipsychotics in the treatment of schizophrenia.

  2003cited by this paper
• Long-acting risperidone: Prolonged-release injectable delivery of risperidone using medisorbò microsphere technology

  2003cited by this paper
• Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method

  2000cited by this paper
• Internal morphology of poly(D,L-lactide-co-glycolide) BCNU-loaded microspheres. Influence on drug stability.

  1998cited by this paper
• The effect of particle microstructure on the somatostatin release from poly(lactide) microspheres prepared by a W/O/W solvent evaporation method

  1995cited by this paper
• Biodegradable microspheres as depot system for patenteral delivery of peptide drugs

  1994cited by this paper

• Epidural pre-formed long-acting implants as a novel and challenging approach for brain drug delivery.

  2025cites this paper
• Research Progress of Sustained-Release Microsphere Technology in Drug Delivery

  2025cites this paper
• Recent Advances in Donepezil Delivery Systems via the Nose-to-Brain Pathway

  2025cites this paper
• Innovative centrifugal microfluidic approach for risperidone-loaded PLGA microsphere production.

  2025cites this paper
• A dataset on formulation parameters and characteristics of drug-loaded PLGA microparticles

  2025cites this paper
• Quantification of Microsphere Drug Release by Fluorescence Imaging with the FRET System

  2024cites this paper
• Artesunate-loaded poly (lactic-co-glycolic acid)/polydopamine-manganese oxides nanoparticles as an oxidase mimic for tumor chemo-catalytic therapy.

  2021cites this paper
• Polymeric microparticle systems for modified release of glucagon-like-peptide-1 receptor agonists

  2021cites this paper
• The PLGA Microspheres Synthesized by a Thermosensitive Hydrogel Emulsifier for Sustained Release of Risperidone

  2021cites this paper
• Engineered PLGA microspheres for extended release of brexpiprazole: in vitro and in vivo studies

  2021cites this paper
• An Update on the Routes for the Delivery of Donepezil.

  2021cites this paper
• Clinically established biodegradable long acting injectables: An industry perspective.

  2020cites this paper
• Quality by Design thinking in the development of long-acting injectable PLGA/PLA-based microspheres for peptide and protein drug delivery.

  2020cites this paper
• Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles.

  2020cites this paper
• "Schizophrenia; a review on promising drug delivery systems".

  2020cites this paper
• Characterizing the release mechanism of donepezil-loaded PLGA microspheres in vitro and in vivo

  2019cites this paper
• The effect of surfactants modification on nanocrystalline cellulose for paclitaxel loading and release study

  2019cites this paper
• Formulation of delivery systems with risperidone based on biodegradable terpolymers

  2018cites this paper
• In vitro evaluation of sustained release of risperidone-loaded microspheres fabricated from different viscosity of PLGA polymers

  2018cites this paper